November 2007 FDA Advisory Panel Recommends That Serevent And Advair Get Stronger Warnings About Use By Children
November 29th, 2007 Posted by: Dr. Cox
Some Panel Members Want Serevent Withdrawn From Market; FDA And GSK Say Asthma Drug Recall Is Not Appropriate
(Posted by Tom Lamb at DrugInjuryWatch.com)
On November 28, 2007 an FDA pediatric advisory panel recommended that the safety warnings on Serevent and Advair needed to be strengthened in order to emphasize the increased risk of hospitalization and death for children using these two asthma drugs from GlaxoSmithKline PLC (GSK).
For some information about the extent of use by children, we get this sales information about